Navigation Links
Cancer is avoidable as you grow older. Here's how.
Date:7/14/2014

Is cancer an inevitable consequence of aging?

Although it is widely thought that cancer is an inevitable consequence of aging, the risk of developing several common cancers decreases with age.

Researchers have long been puzzled by the apparent decrease with age in the risk of developing certain adult cancers.

A possible solution to this puzzle was presented in a recent paper published in Biophysical Reviews and Letters by Professor James P. Brody of the Department of Biomedical Engineering at the University of California, Irvine.

"Most cancers have a characteristic age at which they occur. Testicular cancers mostly occur from age 25-40, bone sarcomas in the teens. Beyond the characteristic age, the incidence of these cancers decreases. Several common cancers appear to have a characteristic age greater than the typical lifespan. Observations of these cancers have led to the belief that the incidence of these cancer increases without limit.

However I believe that we just don't see the decrease of the incidence for some common forms of cancer because people don't live long enough to see it.

One possible explanation is that many cancers originate early in life, possibly before birth. This is called the developmental origin of disease hypothesis. If true, this suggests that a test could be developed that would determine whether a person might develop a specific form of cancer decades before they actually develop it.

Ultimately this test would lead to earlier diagnosis and preventing many forms of cancer from ever developing to the life threatening stage.

Cancer research has three general focal points: how can we diagnose tumors earlier, how can we treat cancer patients to prolong and enhance their lives, and how do tumors originate. This work provides insight into how cancers originate and it may ultimately lead to an understanding of how to reduce the number of cancer patients.


'/>"/>

Contact: Jason Lim Chongjin
cjlim@wspc.com.sg
65-646-65775 x247
World Scientific
Source:Eurekalert  

Page: 1

Related biology news :

1. Antibody halts cancer-related wasting condition
2. Study identifies novel genomic changes in the most common type of lung cancer
3. Sunshine vitamin ups bowel cancer survival odds, study finds
4. Gene mutation may lead to treatment for liver cancer
5. Variations in key gene predict cancer patients risk for radiation-induced toxicity
6. Brain tumor invasion along blood vessels may lead to new cancer treatments
7. DNA origami nano-tool provides important clue to cancer
8. Blocking cells movement to stop the spread of cancer
9. Safer, cheaper building blocks for future anti-HIV and cancer drugs
10. Purdue-designed tool helps guide brain cancer surgery
11. OHSU Knight Cancer Institute researcher wins prestigious early-career award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer is avoidable as you grow older. Here's how.
(Date:1/6/2017)... 2017  Delta ID Inc., a leader in consumer-grade ... automotive at CES® 2017. Delta ID has collaborated with ... the use of iris scanning as a secure, reliable ... in a car, and as a way to elevate ... Delta ID and Gentex will demonstrate (booth #7326 ...
(Date:12/22/2016)... Dec. 20, 2016  As part of its longstanding mission ... personal genetics company, recently released its latest children,s book, titled ... book focuses on the topics of inheritance and variation of ... (NGSS) taught in elementary school classrooms in the US. ... by illustrator Ariana Killoran , whose previous book with ...
(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... SHANGHAI , Jan. 19, 2017 /PRNewswire -- ... medical device open-access capability and technology platform, today ... a leading biology focused preclinical drug discovery contract ... Biosciences will become a wholly-owned subsidiary of WuXi, ... core competences and providing greater services. The acquisition ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., today ... , Ph.D., as chief executive officer, as well ... Dr. Schmidt brings to ArmaGen more than 17 years ... and development of biotherapeutics and pharmaceuticals. ... the diverse experience and skillset necessary to lead ...
(Date:1/19/2017)... Minneapolis, Minnesota (PRWEB) , ... January 19, 2017 ... ... contract research organization with services spanning the full spectrum of drug and device ... clinical research services to pharma/device companies and clinicians, today announced Verified Clinical ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... essential device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 USB 3.0 ... E FPGA into a compact business-card sized form factor suitable for prototyping, testing, ...
Breaking Biology Technology: